#Melanotan #MelanotanII #Tanning #HealthRisks #SkinCancer #Melanoma #Prevention | SKCIN
Retatrutide, a GIP, GLP-1 and glucagon receptor agonist, for people with type 2 diabetes: a randomised, double-blind, placebo and active-controlled, parallel-group, phase 2 trial conducted in the USA
We need authoritative association backed #guidelines for all patients using GLP1 therapies as part of their weight management approach to ensure we protect and promote long term #health ...and whilst we are waiting for those, do check out this open access review paper published in #obesity outlining proposed nutritional recommendations: #digitalhealth Weve had Crohns patients taking GLP-1s for weight loss then refusing to have full NG feeds for fear of regaining the weight that they paid so much to lose
Discover the full range of TB500 peptide products and their benefits here
Real-world safety depends on dose, route of administration, baseline health status, and individual genetic variation
The Precision Peptide Genetic Test reveals predispositions in pathways including FTO rs9939609, MC4R rs17782313, GIPR rs1800437markers that may provide broader context about metabolic regulation and tissue remodeling capacity